These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 24174376)

  • 1. Trends in incidence of primary cutaneous malignancies in children, adolescents, and young adults: a population-based study.
    Senerchia AA; Ribeiro KB; Rodriguez-Galindo C
    Pediatr Blood Cancer; 2014 Feb; 61(2):211-6. PubMed ID: 24174376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
    Criscione VD; Weinstock MA
    Arch Dermatol; 2007 Jul; 143(7):854-9. PubMed ID: 17638728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases.
    Rouhani P; Fletcher CD; Devesa SS; Toro JR
    Cancer; 2008 Aug; 113(3):616-27. PubMed ID: 18618615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing incidence trends of cutaneous T-cell lymphoma.
    Korgavkar K; Xiong M; Weinstock M
    JAMA Dermatol; 2013 Nov; 149(11):1295-9. PubMed ID: 24005876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study.
    Vergamini LB; Frazier AL; Abrantes FL; Ribeiro KB; Rodriguez-Galindo C
    J Pediatr; 2014 Jun; 164(6):1481-5. PubMed ID: 24630354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
    Amber KT; Bloom R; Nouri K
    Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-Specific Incidence of Melanoma in the United States.
    Paulson KG; Gupta D; Kim TS; Veatch JR; Byrd DR; Bhatia S; Wojcik K; Chapuis AG; Thompson JA; Madeleine MM; Gardner JM
    JAMA Dermatol; 2020 Jan; 156(1):57-64. PubMed ID: 31721989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin.
    Coté TR; Sobin LH
    Melanoma Res; 2009 Feb; 19(1):58-60. PubMed ID: 19430407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer in adolescents and young adults (15-29 years): a population-based study in the Netherlands 1989-2009.
    Aben KK; van Gaal C; van Gils NA; van der Graaf WT; Zielhuis GA
    Acta Oncol; 2012 Sep; 51(7):922-33. PubMed ID: 22934554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
    Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
    Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma Incidence in Children and Adolescents: Decreasing Trends in the United States.
    Campbell LB; Kreicher KL; Gittleman HR; Strodtbeck K; Barnholtz-Sloan J; Bordeaux JS
    J Pediatr; 2015 Jun; 166(6):1505-13. PubMed ID: 25866386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant melanoma incidence among children and adolescents in Texas and SEER 13, 1995-2013.
    Danysh HE; Navai SA; Scheurer ME; Hunt R; Venkatramani R
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27648. PubMed ID: 30729662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin cancer. Melanoma and other specific nonmelanoma skin cancers.
    Elder DE
    Cancer; 1995 Jan; 75(1 Suppl):245-56. PubMed ID: 8000999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006-11.
    Sella T; Goren I; Shalev V; Shapira H; Zandbank J; Rosenblum J; Kimlin MG; Chodick G
    Br J Dermatol; 2015 Jan; 172(1):202-7. PubMed ID: 24976239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent patterns in cutaneous melanoma descriptive epidemiology in the Slovak Republic.
    Ondrusova M; Mrinakova B; Ondrus D; Polakova K; Durdik S
    Neoplasma; 2013; 60(6):706-13. PubMed ID: 23906306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer incidence patterns among adolescents and young adults in the United States.
    Wu X; Groves FD; McLaughlin CC; Jemal A; Martin J; Chen VW
    Cancer Causes Control; 2005 Apr; 16(3):309-20. PubMed ID: 15947883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma.
    Schenk M; Severson RK; Pawlish KS
    Cancer; 1998 May; 82(9):1672-6. PubMed ID: 9576287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.